Hartford Equity Income Fund (I share) underperformed the Russell 1000 Value Index during the quarter. Read more here.

As biosimilar versions of a big-selling Johnson & Johnson medicine reach the U.S. market, the health care giant accused one ...

Johnson & Johnson (NYSE:JNJ) is reportedly suing Samsung Bioepis for breach of contract related to the launch of a biosimilar ...

Johnson & Johnson said on Monday it had filed a lawsuit against Samsung Bioepis for breaching its contract agreement with the ...

The Franklin U.S. Low Volatility High Dividend ETF has a portfolio of 111 stocks selected based on yield, price volatility, ...

Intra-Cellular reports mixed fourth-quarter 2024 results, wherein earnings miss estimates but revenues beat the same driven ...

The most talked about and market moving research calls around Wall Street are now in one place. Here are today’s research calls that investors ...

We recently published a list of 10 Best DRIP Stocks To Own Now. In this article, we are going to take a look at where Johnson ...

A higher dividend yield is nice because it allows you to collect more dividend income on every dollar you invest in a stock.

Mizuho analyst Graig Suvannavejh downgraded Intra-Cellular (ITCI) to Neutral from Outperform with a price target of $132, down from $140, ...

Kentucky Retirement Systems Insurance Trust Fund increased its stake in Johnson & Johnson by 40.2%, owning 99,915 shares ...